Phase 1-2 Trial HCQ Plus TACE in Unresectable HCC
Clinical trial NCT02013778 · TERMINATED
Trial details
- NCT number
- NCT02013778
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2018-11-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.